CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 51 enrolled
Drug / intervention
Hydroxytyrosoldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02068092
NCT02068092Phase 3Completed
CompareCT.gov

A Pilot Study of Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention In Women At High Risk Of Breast Cancer

The Methodist Hospital Research Institute·interventional·Posted Feb 21, 2014·Updated Oct 10, 2023

In Brief

A Phase 3 clinical trial evaluating Hydroxytyrosol for Breast Cancer. Completed, enrolled 51 participants across 3 sites.

Detailed Summary

This is a pilot study evaluating the effect of hydroxytyrosol, a component of olive oil, on mammographic density in women at high risk of developing breast cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 21, 2014
Enrollment StartDec 1, 2013
Primary CompletionJul 1, 2021
TodayJul 2, 2026
Enrollment to primary: 7.6 yearsPosted 12.4 years ago

Interventions

Hydroxytyrosoldrug